Synthesis and anti-HSV-1 evaluation of new 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines and 3H-pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridines

Organic and Medicinal Chemistry Letters - Tập 2 Số 1 - 2012
Alice M. R. Bernardino1, A. Azevedo1, Luiz C. S. Pinheiro1, Júlio César Borges1, Izabel Cp Paixão2, Maria Gefé da Rosa Mesquita2,3, Thiago Moreno L. Souza2,3, Maurício Silva dos Santos4
1Departamento de Química Orgânica, Instituto de Química, Programa de Pós-Graduação em Química, Universidade Federal Fluminense, Niterói, Brazil
2Departamento de Biologia Celular e Molecular, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil
3Programa de Pós-Graduação em Biologia Celular e Molecular, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil
4Departamento de Física e Química, Instituto de Ciências Exatas, Universidade Federal de Itajubá, Itajubá, Brazil

Tóm tắt

Abstract Background Herpes simplex virus type-1 (HSV-1) is the primary cause of facial lesions (mouth, lips, and eyes) in humans. The widespread use of acyclovir and nucleoside analogues has led to emergence of HSV strains that are resistant to these drugs. Recently, non-nucleoside anti-HSV compounds have received considerable attention. 1,6-Naphthyridines are a class of heterocyclic compounds that exhibit a broad spectrum of biological activities such as inhibitor of HIV-1 integrase, HCMV, FGF receptor-1 tyrosine kinase, and the enzyme acetylcholinesterase. We previously reported the synthesis, SAR studies, and evaluation anti-HSV-1 activity of 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines. In the course of our search for new 1,6-naphthyridines derivatives with potential activity against HSV-1, we have synthesized and evaluated new 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines (1a-k) and 3H-pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridines (2a-c). Results A known synthetic approach was used for preparing new 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines (1a-k) and 3H-pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridines (2a-c), starting from ethyl 4-chloro-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (7). All compounds were identified by FTIR, 1H NMR, and mass spectrometry. The antiviral effect on HSV-1 virus replication was determined. Conclusions The compounds 1d, 1f, 1g, and 1h exhibited the highest anti-HSV-1 activity. In general, 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines were more effective inhibitors than their corresponding 3H-pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridines. The compound 1h reduced the virus yield in 91% at 50 μM and exhibited a low cytotoxicity (CC50 600 μM).

Từ khóa


Tài liệu tham khảo

James SH, Kimberlin DW, Whitley RJ: Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res 2009, 83: 207–213. 10.1016/j.antiviral.2009.04.010

Knizewski Ł, Kinch L, Grishin NV, Rychlewski L, Ginalski K: Human herpesvirus 1 UL24 gene encodes a potential PD-(D/E)XK endonuclease. J Virol 2006, 80: 2575–2577. 10.1128/JVI.80.5.2575-2577.2006

Kang IJ, Wang LW, Hsu TA, Yueh A, Lee CC, Lee YC, Lee CY, Chao YS, Shih SR, Chern JH: Isatin-b-thiosemicarbazones as potent herpes simplex virus inhibitors. Bioorg Med Chem Lett 2011, 21: 1948–1952. 10.1016/j.bmcl.2011.02.037

Jerome KR: The road to new antiviral therapies. Clin Appl Immunol Rev 2005, 5: 65–76. 10.1016/j.cair.2004.10.002

Morfin F, Thouvenot D: Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003, 26: 29–37. 10.1016/S1386-6532(02)00263-9

Mohamed SF, Flefel EM, Amr AEE, El-Shafy DNA: Anti-HSV-1 activity and mechanism of action of some new synthesized substituted pyrimidine, thiopyrimidine and thiazolopyrimidine derivatives. Eur J Med Chem 2010, 45: 1494–1501. 10.1016/j.ejmech.2009.12.057

Ju HQ, Xiang YF, Xin BJ, Pei Y, Lu JX, Wang QL, Xia M, Qian CW, Ren Z, Wang SY, Wang YF, Xing GW: Synthesis and in vitro anti-HSV-1 activity of a novel Hsp 90 inhibitor BJ-B11. Bioorg Med Chem Lett 2011, 21: 1675–1677. 10.1016/j.bmcl.2011.01.098

Jordão AK, Ferreira VF, Souza TML, Faria GGS, Machado V, Abrantes JL, Souza MCBV, Cunha AC: Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives. Bioorg Med Chem 2011, 19: 1860–1865. 10.1016/j.bmc.2011.02.007

Gudmundsson KS, Johns BA, Weatherhead J: Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses. Bioorg Med Chem Lett 2009, 19: 5689–5692. 10.1016/j.bmcl.2009.08.009

Lowden CT, Bastow KF: Anti-Herpes simplex virus activity of substituted 1-hydroxyacridones. J Med Chem 2003, 46: 5015–5020. 10.1021/jm030206l

Hammond JL, Koontz DL, Bazmi HZ, Beadle JR, Hostetler SE, Kini GD, Aldern KA, Richman DD, Hostetler KY, Mellors JW: Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance. Antimicrob Agents Chemother 2001, 45: 1621–1628. 10.1128/AAC.45.6.1621-1628.2001

Ramkumar K, Serrao E, Odde S, Neamati N: HIV-1 integrase inhibitors: 2007–2008 update. Med Res Rev 2010, 30: 890–954. 10.1002/med.20194

Johns BA, Weatherhead JG, Allen SH, Thompson JB, Garvey EP, Foster SA, Jeffrey JL, Miller WH: 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position. Bioorg Med Chem Lett 2009, 19: 1807–1810. 10.1016/j.bmcl.2009.01.089

Melamed JY, Egbertson MS, Varga S, Vacca JP, Moyer G, Gabryelski L, Felock PJ, Stillmock KA, Witmer MV, Schleif W, Hazuda DJ, Leonard Y, Jin L, Ellis JD, Young SD: Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase. Bioorg Med Chem Lett 2008, 18: 5307–5310. 10.1016/j.bmcl.2008.08.038

Egbertson MS, Moritz HM, Melamed JY, Han W, Perlow DS, Kuo MS, Embrey M, Vacca JP, Zrada MM, Cortes AR, Wallace A, Leonard Y, Hazuda DJ, Miller MD, Felock PJ, Stillmock KA, Witmer MV, Schleif W, Gabryelski LJ, Moyer G, Ellis JD, Jin L, Xu W, Braun MP, Kassahun K, Tsou NN, Young SD: A potent and orally active HIV-1 integrase inhibitor. Bioorg Med Chem Lett 2007, 17: 1392–1398. 10.1016/j.bmcl.2006.11.080

Falardeau G, Lachance H, Pierre AS, Yannopoulos CG, Drouin M, Bédard J, Chan L: Design and synthesis of a potent macrocyclic 1,6-napthyridine anti-human cytomegalovirus (HCMV) inhibitors. Bioorg Med Chem Lett 2005, 15: 1693–1695. 10.1016/j.bmcl.2005.01.050

Chan L, Jin H, Stefanac T, Lavallée JF, Falardeau G, Wang W, Bédard J, May S, Yuen L: Discovery of 1,6-Naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors. J Med Chem 1999, 42: 3023–3025. 10.1021/jm9902483

Thompson AM, Connolly CJC, Hamby JM, Boushelle S, Hartl BG, Amar AM, Kraker AJ, Driscoll DL, Steinkampf RW, Patmore SJ, Vincent PW, Roberts BJ, Elliott WL, Klohs W, Leopold WR, Showalter HDH, Denny WA: 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase. J Med Chem 2000, 43: 4200–4211. 10.1021/jm000161d

Vanlaer S, Voet A, Gielens C, De Maeyer M, Compernolle F: Bridged 5,6,7,8-tetrahydro-1,6-naphthyridines, analogues of huperzine a: synthesis, modeling studies and evaluation as inhibitors of acetylcholinesterase. Eur J Org Chem 2009, 2009: 643–654.

Brown DJ (Ed): Chemistry of heterocyclic compounds: the naphthyridines John Wiley & Sons, New Jersey; 2008.

Jachak MN, Bagul SM, Kazi MA, Toche RB: Novel synthetic protocol toward pyrazolo[3,4- h ]-[1,6]naphthyridines via Friedlander condensation of new 4-aminopyrazolo[3,4- b ]pyridine-5-carbaldehyde with reactive α-methylene ketones. J Het Chem 2011, 48: 295–300. 10.1002/jhet.242

Rote RV, Bagul SM, Shelar DP, Patil SR, Toche RB, Jachak MN: Synthesis of benzo[3,4- h ][1,6]naphthyridines via Friedlander condensation with active methylenes. J Het Chem 2011, 48: 301–307. 10.1002/jhet.391

Toche RB, Pagar BP, Zoman RR, Shinde GB, Jachak MN: Synthesis of novel benzo[h][1,6]naphthyridine derivatives from 4-aminoquinoline and cyclic b-ketoester. Tetrahedron 2010, 66: 5204–5211. 10.1016/j.tet.2010.04.085

Chandra A, Singh B, Upadhyay S, Singh RM: Copper-free Sonogashira coupling of 2-chloroquinolines with phenyl acetylene and quick annulation to benzo[b][1,6]naphthyridine derivatives in aqueous ammonia. Tetrahedron 2008, 64: 11680–11685. 10.1016/j.tet.2008.10.010

Bernardino AMR, Castro HC, Frugulhetti ICPP, Loureiro NIV, Azevedo AR, Pinheiro LCS, Souza TML, Giongo V, Passamani F, Magalhães UO, Albuquerque MG, Cabral LM, Rodrigues CR: SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine series. Bioorg Med Chem 2008, 16: 313–321. 10.1016/j.bmc.2007.09.032

Leal B, Afonso IF, Rodrigues CR, Abreu PA, Garrett R, Pinheiro LCS, Azevedo AR, Borges JC, Vegi PF, Santos CCC, Silveira FCA, Cabral LM, Frugulhetti ICPP, Bernardino AMR, Santos DO, Castro HC: Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives. Bioorg Med Chem 2008, 16: 8196–8204. 10.1016/j.bmc.2008.07.035

Mello H, Echevarria A, Bernardino AM, Cavalheiro MC, Leon LL: Antileishmanial pyrazolopyridine derivatives: synthesis and structure-activity relationship analysis. J Med Chem 2004, 47: 5427–5432. 10.1021/jm0401006

Bernardino AMR, Azevedo AR, Pinheiro LCS, Borges JC, Carvalho VL, Miranda MD, Meneses MDF, Nascimento M, Ferreira D, Rebello MA, Silva VAGG, Frugulhetti ICPP: Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl)amino]-1-phenyl-1 H -pyrazolo[3,4- b ]pyridine-4-carboxylic acids derivatives. Med Chem Res 2007, 16: 352–369. 10.1007/s00044-007-9035-6

Pinheiro LCS, Borges JC, Oliveira CD, Ferreira VF, Romeiro GA, Marques IP, Abreu PA, Frugulhetti ICPP, Rodrigues CR, Albuquerque MG, Castro HC, Bernardino AMR: Synthesis of new 4-(phenylamino)thieno[2,3-b]pyridines and derivatives of the novel benzo[b]thieno[3,2-h]-1,6-naphthyridine tetracyclic system. Arkivoc 2008, 14: 77–87.

Bernardino AMR, Pinheiro LCS, Rodrigues CR, Loureiro NI, Castro HC, Rangel AL, Lopes JS, Borges JC, Carvalho JM, Romeiro GA, Ferreira VF, Frugulhetti ICPP, Santos MAV: Design, synthesis, SAR, and biological evaluation of new 4-(phenylamino)thieno[2,3-b]pyridine derivatives. Bioorg Med Chem 2006, 14: 5765–5770. 10.1016/j.bmc.2006.03.013

Thông tin
Thông tin xuất bản

Organic and Medicinal Chemistry Letters

Tập 2 Số 1

Thông tin tác giả